Preparing for the EU Health Technology Assessment: Key Insights from the Upcoming 2026 Webinar

By João L. Carapinha

January 5, 2026

The European Commission is organizing a webinar set for 15 January 2026 for health technology developers of medicinal products. The event provides guidance on EU Health Technology Assessment (HTA) Regulation prep, focused on Joint Clinical Assessments (JCAs) for certain medicinal products, with topics including dossier submissions, timelines, and EU HTA Coordination Group interactions. Practical sessions will cover regulatory processes, and registration stays open until mid-January 2026.

The EU HTA Regulation (EU) 2021/2282 is key, as endorsed by the European Parliament and Council, and it sets a voluntary framework that evolves to mandatory JCAs with goals including less duplication in HTA and boosting efficiency across 27 member states. See details on official EU Health Technology webpages.

Reference url

Recent Posts

Global Growth and Challenges in Pharmacy Vaccination Training

By João L. Carapinha

May 13, 2026

Pharmacy Vaccination Training has expanded rapidly worldwide, with the number of countries offering pharmacist vaccination programs rising from 12 in 2016 to 64 by 2024. This 433 percent growth means training is now available in every nation where pharmacists may administer vaccines, including pr...
Key Strategies in Neonatal Infection Management: Insights from NICE Guideline NG195

By João L. Carapinha

The NICE guideline NG195 establishes a structured framework for neonatal infection management in newborns up to 28 days corrected gestational age, treating at-risk pregnant individuals, and managing suspected or confirmed infections in neonates. It emphasizes timely recognition to avoid delays, j...
Merck Oncology Advancements Highlight Long-Term Data and Pipeline Progress at ASCO 2026

By HEOR Staff Writer

Merck oncology advancements continue to deliver meaningful progress for patients. New long-term data from multiple trials highlight sustained survival benefits across lung cancer, breast cancer, melanoma, and other tumor types. These advancements will feature prominently at the 2026 American S...